SGPL1 and myeloid sarcoma: Therefore, the result of this study only demonstrates the immune suppression role of SPL inhibition in the induction of EAE disease; however, whether SPL inhibition plays a therapeutic role in preventing against neurodegeneration in the context of MS is unclear.